NCT00232479 - Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions

Breast Cancer

Interventions

DRUG

trastuzumab, docetaxel and carboplatin in dose dense regimen

trastuzumab 4 mg/kg day 1 and then 2 mg/kg/week x 11, carboplatin 6 mg AUC Day 1, 15, 29, 43, docetaxel 75 mg/meter squared Days 1, 15, 29, 43, neulasta 6 mg Day 2, 16, 30, 44

Trial Locations (1)

33136

Jackson Memorial Hospital, Miami